- Country: Chile
- Summary: Medroxiprgesterone Acetate 15000 Mg Injectable
- CLT Ref No: 117544490
- Deadline: 17 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CLP 10268510
- Notice Type: Tender
- Document Ref. No.: 1057536-25-LE25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Acquisition of 3310 units of medroxiprgesterone acetate 150.00 mg1 ml injectable suspension. Delivery Direction Seminary SN Ex Hospital de Puerto Montt, Bodega Drugguard. The supplier must attach to its offer letter related to the policy of exchange per expiration of the drugTendered, which must comply, otherwise the supplier is subject to fines for breaches in hiring. It is worth mentioning that the provider will be the withdrawal and replacement of the drug.
Products or services:Nongetrel - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedroxiprgesterone Acetate 15000 Mg Injectable - Chile Tender
The RELONCAVI HEALTH SERVICE, a Government sector organization in Chile, has announced a new tender for Medroxiprgesterone Acetate 15000 Mg Injectable. This tender is published on ChileTenders under CLT Ref No: 117544490 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-17.
The estimated tender value is CLP 10268510, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
